04/22/2026
We are honored to recognize our collaboration with Hitachi High-Tech Corporation in the development of the PrepQuant™ System, an integrated platform for nucleic acid extraction, concentration, and quantification.
By bringing together Invivoscribe’s expertise in standardized molecular assays and global clinical testing with Hitachi High-Tech’s strengths in engineering and manufacturing, this partnership has enabled the creation of a fully automated solution designed to standardize pre-analytical workflows and reduce variability in molecular applications.
The PrepQuant™ System reflects our shared commitment to quality, precision, and continuous innovation. We sincerely thank the Hitachi High-Tech team for their collaboration, dedication, and trust throughout this development.